CJC-1295, Ipamorelin

CJC-1295 and Ipamorelin are two growth hormone–stimulating peptides often studied together for their synergistic effects on growth hormone (GH) release. In preclinical models, this combination has been of interest for supporting cellular repair, muscle recovery, tissue regeneration, and metabolic function. CJC-1295 acts on GHRH pathways for prolonged GH
signaling, while Ipamorelin selectively stimulates GH release without significant effects on cortisol or prolactin. Research frequently explores this combination in models involving musculoskeletal recovery, body composition, tissue repair, and metabolic regulation.